Healthy Returns: Eli Lilly makes a new push into vaccines — here’s what to know

Healthy Returns: Eli Lilly makes a new push into vaccines — here’s what to know

The drugmaker announced it will buy three privately held vaccine makers in deals worth almost $4 billion combined.

When Eli Lilly Pivots, TMED’s Strategy Wins

The T. Rowe Price Health Care ETF (TMED) led all T. Rowe Price funds last week, posting a 3.4% return. The gains came as TMED’s top holding, Eli Lilly and Co. (LLY), announced plans to acquire three vaccine developers for up to $3.83 billion. Key Takeaways: TMED posted a 3.37% return last week, the top [...] The post When Eli Lilly Pivots, TMED’s Strategy Wins appeared first on ETF Trends.